The ageing of Cystic Fibrosis patients with new modulators: current gaps and challenges

Expert Rev Respir Med. 2023 Dec;17(12):1091-1094. doi: 10.1080/17476348.2024.2311109. Epub 2024 Feb 12.

Authors

Almudena Felipe Montiel¹, Antonio Álvarez Fernández^{1

2}, Letizia Traversi¹, Eva Polverino^{1

2}

Affiliations

¹ Department of Respiratory Medicine (Adult Cystic Fibrosis Unit), Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
² CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

PMID: 38347811
DOI: 10.1080/17476348.2024.2311109

No abstract available

Keywords: Adult Cystic Fibrosis; CFTR modulators; aging; clinical challenges; comorbidities.

Publication types

Editorial

MeSH terms

Aging
Aminophenols / therapeutic use
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis* / drug therapy
Humans
Mutation

Substances

Cystic Fibrosis Transmembrane Conductance Regulator
Aminophenols